Deep search
Search
Images
Videos
Maps
News
Shopping
Copilot
More
Flights
Travel
Hotels
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
FDA approves Spravato, first monotherapy nasal spray to treat depression
The Food and Drug Administration has approved the first-ever stand-alone nasal spray to treat drug-resistant depression. Johnson & Johnson's Spravato was approved to treat a major depressive disorder,
J&J's ketamine-derived nasal spray approved by FDA to treat depression
Johnson & Johnson's ketamine-derived nasal spray has been approved as a standalone treatment to fight depression for those who had an inadequate response to oral antidepressants.
Nose spray to treat depression? FDA approves first-of-its-kind medicine
The U.S. Food and Drug Administration has approved a nose spray to help treat depression, Johnson & Johnson announced Tuesday.
JNJ's SNDA For Spravato Monotherapy Gets FDA Approval For Treatment-Resistant Depression
Tuesday announced that the U.S. Food and Drug Administration has approved supplemental New Drug Application or sNDA for Spravato, a monotherapy for adults with treatment-resistant depression, a psychiatric disorder.
Johnson & Johnson Gets FDA OK For Spravato as Monotherapy
Johnson & Johnson has won Food and Drug Administration expanded approval of its Spravato nasal spray as a lone therapy for adults with treatment-resistant depression. J&J on Tuesday said the green light makes Spravato the first and only monotherapy for adults with major depressive disorder who have had an inadequate response to at least two oral antidepressants.
US FDA approves J&J's ketamine-based therapy to treat depression
The U.S. Food and Drug Administration approved Johnson & Johnson's ketamine-based nasal spray Spravato to treat adults with major depressive disorder, the company said on Tuesday. The approval paves the way for use of Spravato in patients whose disease has stopped responding to at least two oral anti-depressants.
4h
on MSN
'They treat us very, very badly': Trump plans to hit European Union with tariffs, 10% rate on China
US President Donald Trump has threatened tariffs on the EU and China to address trade imbalances and combat fentanyl ...
2h
on MSN
Treat of the Day: TAMU Meat Judging team earns Reserve Champion
BRYAN, Texas (KBTX) - The Fightin' Texas Aggie Meat Judging Team kicked off their season with Reserve Champion Team honors at the National Western Meat Judging Contest held in Greeley, Colorado this ...
6h
on MSN
Treat eating disorders as an emergency, MPs urge
Lives are being lost and families torn apart because of "woefully inadequate care" for people with eating disorders, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
Los Angeles wildfire updates
California fires: How to help
Released from prison
Milley's portrait taken down
Agent fatally shot in VT
Former prosecutor faces trial
National championship win
Gulf Coast winter storm
Elise Stefanik testifies
SCOTUS grants new hearing
Judge blocks report release
FDA approves nasal spray
Coast Guard chief fired
Acting defense secretary
Trailblazing cartoonist dies
Fire at ski resort in Turkey
'Days of Our Lives' star dies
Birthright citizenship suit
CBP One app shut down
Antisemitism lawsuits settled
To host '25 Grammy Awards
Doug Collins hearing
Djokovic beats Alcaraz
Raising prices again
Discuss strengthening ties
Israel’s top general resigns
Silk Road founder pardoned
Can target schools, churches
1st Japanese elected to HOF
Israel raids West Bank
Feedback